Aptamerized silica/gold nanocapsules for stimulated release of doxorubicin through remote two-photon excitation
Source abstract
Abstract
Precision-based drug delivery via remote triggering is fast becoming an attractive therapeutic design and is highly useful in complicated clinical situations that may require accurate site-delivery of drug while reducing the risk of collateral damage to surrounding healthy tissue. Of the many strategies available to achieve these desirable effects, silica/gold nano-assemblies offers a practical means to achieving these aims. Herein, as a proof-of-concept, a silica nanocapsule passivated with a gold outer nanoshell had been fabricated to deliver Doxorubicin, and this nano-assembly can be remotely triggered via two-photon excitation (TPE), even under in vivo setting. A polyethylene glycol (PEG) layer as well as AS1411 DNA aptamer had also been grafted to the surface to improve homing specificity toward MDA-MB-231 breast cancer tissue. The assembly of silica/gold nanocapsules was characterized via TEM, FTIR, and UV-Vis to validate the the nanoconstruct. Upon TPE irradiation, a higher expression level of Annexin V and Caspase-3 was observed in both in vitro and in vivo animal models. A significant reduction in tumor size on mice model was noticed after 21 days, and these results had suggested a viable nano-sized design serving as remotely triggered drug release platform based on current well-established silica nanoparticulate methodologies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory Service, Bagan Specialist Centre, Butterworth, Malaysia
Department of Biological Science and Technology, China Medical University, Taichung, Taiwan
Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Taiwan
Department of Cosmeceutics, China Medical University, Taichung, Taiwan
Funding
Ministry of Science and Technology, Taiwan
References (39)
Show source-provided references
1. 10.1016/S0006-3495(01)76173-510.1016/S0006-3495(01)76173-5 ↗
2. 10.1002/anie.20150780010.1002/anie.201507800 ↗
3. 10.1016/j.addr.2015.09.00910.1016/j.addr.2015.09.009 ↗
4. 10.1039/C6CS00442C10.1039/C6CS00442C ↗
5. 10.1021/am405214w10.1021/am405214w ↗
6. 10.1016/j.mrfmmm.2011.02.01210.1016/j.mrfmmm.2011.02.012 ↗
7. 10.1016/j.ijrobp.2009.06.06510.1016/j.ijrobp.2009.06.065 ↗
8. 10.1038/bjc.2016.11110.1038/bjc.2016.111 ↗
9. 10.1038/nmat377610.1038/nmat3776 ↗
10. 10.1016/j.addr.2008.03.01210.1016/j.addr.2008.03.012 ↗
11. 10.1002/anie.20060448810.1002/anie.200604488 ↗
12. 10.1039/C3CS60273G10.1039/C3CS60273G ↗
13. 10.1126/science.276.5314.92310.1126/science.276.5314.923 ↗
14. 10.1021/nn100690m10.1021/nn100690m ↗
15. 10.1021/la015561y10.1021/la015561y ↗
16. 10.1088/0957-4484/22/36/36510210.1088/0957-4484/22/36/365102 ↗
17. 10.7150/thno.893410.7150/thno.8934 ↗
18. 10.1166/jbn.2016.219510.1166/jbn.2016.2195 ↗
19. 10.1158/1535-7163.MCT-06-017210.1158/1535-7163.MCT-06-0172 ↗
20. 10.3390/s12010061210.3390/s120100612 ↗
21. 10.3390/molecules2311285110.3390/molecules23112851 ↗
22. 10.1021/la00033a01010.1021/la00033a010 ↗
23. 10.1021/nn900883d10.1021/nn900883d ↗
24. 10.1038/s41598-017-00912-310.1038/s41598-017-00912-3 ↗
25. 10.1021/la305062610.1021/la3050626 ↗
26. 10.1172/JCI11949510.1172/JCI119495 ↗
27. 10.1080/10837450.2019.156967810.1080/10837450.2019.1569678 ↗
28. 10.1016/j.talanta.2020.12103710.1016/j.talanta.2020.121037 ↗
29. 10.1016/j.ijbiomac.2019.11.11810.1016/j.ijbiomac.2019.11.118 ↗
30. 10.1016/S1386-1425(03)00082-910.1016/S1386-1425(03)00082-9 ↗
31. 10.1182/blood-2006-08-04325710.1182/blood-2006-08-043257 ↗
32. 10.1158/0008-5472.CAN-07-572310.1158/0008-5472.CAN-07-5723 ↗
33. Derenzini M · Lab Invest · 1995 · 73 · 497
34. 10.1021/jp036222b10.1021/jp036222b ↗
35. 10.1016/j.micromeso.2012.12.03410.1016/j.micromeso.2012.12.034 ↗
36. 10.1021/jp045167j10.1021/jp045167j ↗
37. 10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L ↗
38. 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R ↗
39. 10.1083/jcb.140.6.148510.1083/jcb.140.6.1485 ↗